Related Experiment Video

Updated: May 17, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

The lipid story in chronic kidney disease: a long story with a happy end?

Agata Kujawa-Szewieczek1, Andrzej Więcek, Grzegorz Piecha

  • 1Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, ul. Francuska 20-24, 40-027, Katowice, Poland.

International Urology and Nephrology
|October 12, 2012
PubMed

Insights

Cardiovascular disease risk is high in chronic kidney disease (CKD) patients. Statins are recommended for CKD stages 1-4 and dialysis patients to reduce cardiovascular events.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Pharmacology

Background:

  • Cardiovascular disease (CVD) is a major cause of mortality in patients with chronic kidney disease (CKD), with rates significantly higher than in the general population.
  • Dyslipidemia is a known CVD risk factor, but its specific impact and management in CKD patients remain less understood.
  • Despite proven benefits in non-CKD populations, statin use is less frequent in CKD patients due to historical data limitations.

Discussion:

  • The Study of Heart and Renal Protection (SHARP) trial provides crucial data on statin efficacy and safety specifically in CKD patients.
  • The findings support the use of statins as a viable treatment option for managing dyslipidemia and reducing CVD risk in this vulnerable group.
  • Addressing lipid disorders is critical for improving cardiovascular outcomes in individuals with impaired kidney function.

Key Insights:

  • Statins demonstrate safety and potential efficacy in reducing atherosclerotic events and cardiac mortality in CKD patients.
  • Evidence now supports increased prescription of statins for individuals across CKD stages 1-4.
  • Patients undergoing dialysis also stand to benefit from statin therapy for cardiovascular risk reduction.

Outlook:

  • Further research may explore optimal statin regimens and long-term outcomes in diverse CKD populations.
  • Increased clinical adoption of statins in CKD management is anticipated.
  • This could lead to a significant reduction in the burden of cardiovascular morbidity and mortality associated with kidney disease.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...